Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Neel Butala to Risk Assessment

This is a "connection" page, showing publications Neel Butala has written about Risk Assessment.

 
Connection Strength
 
 
 
0.922
 
  1. Butala NM, Faridi KF, Secemsky EA, Song Y, Curtis J, Gibson CM, Kazi D, Shen C, Yeh RW. Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting. J Am Heart Assoc. 2021 03 16; 10(6):e018744.
    View in: PubMed
    Score: 0.371
  2. Butala NM, Hebbe A, Shah B, Smilowitz NR, Aijaz B, Uzendu A, Boulos P, Waldo SW. Outcomes After Noncardiac Surgery Performed Within 2?Years of Percutaneous Coronary Intervention. J Am Heart Assoc. 2025 Mar 18; 14(6):e038807.
    View in: PubMed
    Score: 0.123
  3. Butala NM, Lalani C, Tale A, Song Y, Kolte D, Baron S, Strom J, Cohen DJ, Yeh RW. Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Circ Cardiovasc Interv. 2025 Jan; 18(1):e014592.
    View in: PubMed
    Score: 0.121
  4. Butala NM, Kapadia SR, Yeh RW, Cohen DJ. Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013698.
    View in: PubMed
    Score: 0.116
  5. Butala NM, Kapadia SR, Secemsky EA, Gallup D, Kosinski AS, Vemulapalli S, Messenger JC, Yeh RW, Cohen DJ. Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013697.
    View in: PubMed
    Score: 0.116
  6. Lalani C, Medina F, Oseran AS, Liang L, Song Y, Butala NM, Kazi DS, Cohen DJ, Strom JB, Wadhera RK, Yeh RW. Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes. 2025 May; 18(5):e011991.
    View in: PubMed
    Score: 0.031
  7. Faridi KF, Garratt KN, Kennedy KF, Maddox TM, Secemsky EA, Butala NM, Yeh RW. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e006275.
    View in: PubMed
    Score: 0.022
  8. Strom JB, Zhao Y, Faridi KF, Tamez H, Butala NM, Valsdottir LR, Curtis J, Brennan JM, Shen C, Boulware M, Popma JJ, Yeh RW. Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study. Circ Cardiovasc Interv. 2019 11; 12(11):e008231.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)